Contesting consent: the challenge to compulsory neonatal screening for pku

Perspectives in Biology and Medicine

Volumn 42, Issue 2, 1999, Pages 207-219

  Paul, Diane ^a  

^a UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECISION MAKING; DIAGNOSTIC VALUE; GENETIC SCREENING; HUMAN; INFORMED CONSENT; NEWBORN SCREENING; PHENYLKETONURIA; PRIORITY JOURNAL; REVIEW; SCREENING TEST;

ANALYTICAL APPROACH; COSTS AND BENEFITS; EMPIRICAL RESEARCH; GENETICS AND REPRODUCTION; HEALTH CARE AND PUBLIC HEALTH; MANDATORY PROGRAMS; MORAL POLICY; PARENTAL CONSENT; PROFESSIONAL PATIENT RELATIONSHIP; RISKS AND BENEFITS; UNITED STATES; VOLUNTARY PROGRAMS;

EMPIRICAL RESEARCH; ETHICS, MEDICAL; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FREEDOM; GENETIC DISEASES, INBORN; HUMANS; INFANT, NEWBORN; INFORMED CONSENT; MANDATORY PROGRAMS; MANDATORY TESTING; MORAL OBLIGATIONS; NEONATAL SCREENING; PARENTAL CONSENT; PATIENT ADVOCACY; PHENYLKETONURIAS; PHYSICIAN-PATIENT RELATIONS; RISK ASSESSMENT; VOLUNTARY PROGRAMS;

EID: 0033278265     PISSN: 00315982     EISSN: None     Source Type: Journal    
DOI: 10.1353/pbm.1999.0032     Document Type: Article

References (49)

1. ANDREWS, L.B.; FULLARTON, J.E.; HOLTZMAN, N.A.; and MOTULSKY, A.G., eds. Assessing Genetic Risks: Implications for Health and Social Policy. Washington, DC: National Academy Press, 1994. 51, 66, 70, 162.
2. Public Law 94-278 (1976), Title IV, 403(a), 90 Stat. 408.
3. NATIONAL RESEARCH COUNCIL. Genetic Screening: Programs, Principles, and Research. Washington, DC: National Academy of Sciences, 1975. 50-51.
4. FADEN, R.A.; CHWALOW, J.; HOLTZMAN, N.A.; and HORN, S.D. A survey to evaluate parental consent as public policy for neonatal screening. Am. J. Public Health 72:1347-51, 1982.
5. HILLER, E.H.; LANDENBURGER, G.; and NATOWICZ, M.R. Public participation in medical policy making and the status of consumer autonomy: The example of newborn screening programs in the United States. Am.J. Public Health 87:1280-88, 1997.
6. TLUCZEK, A., et al. Parents' knowledge of neonatal screening and response to false-positive cystic fibrosis testing. J. Devel. Behav. Pedialr. 13:181-86, 1992.
7. WERTZ, D.C.; ELETCHER, J.C.; BERG, K.; and BOULYJENKOV, V. Guidelines on Ethical Issues in Medical Genetics and the Provision of Genetics Services. World Health Organization, 1995. 35.
8. AMERICAN COLLEGE OF MEDICAL GENETICS. Joint Committee on Professional Practice. Statement, July 1994. Circulated in a memorandum to ACMG fellows and members, by David L. Rimoin, M.D., President, 1 August 1994.
9. PAUL, D.B. The history of newborn phenylketonuria screening in the U.S. In Promoting Safe and Effective Genetic Testing in the United States: Final Report of the Task Force on Genetic Testing, edited by N.A. HOLTZMAN and M.S. WATSON. Baltimore: Johns Hopkins UP, 1998. 137-60.
10. Final Report of the Advisory Committee on Human Radiation Experiments. New York: Oxford UP, 1996. 80, 97-103.
11. ANNAS, G.J. Mandatory PKU screening: The other side of the looking glass. Am.J. Public Health 72:1401-3, 1982.
12. PAUL, D.B., and EDELSON, P.J. The struggle over screening. In Alolecularising Biology and Medicine: Neiu Practices and Alliances, 1930s-1970s, edited by S. DE CHADAREVIAN and H. KAMMINGA. Reading: Harwood Academic Publishers, 1998. 203-20.
13. HOLTZMAN, N.A. Dietary treatment of inborn errors of metabolism. Ann. Rev. Med. 21:335-56, 1970.
14. HOLTZMAN, N.A.; LAPIDES, J.L.; and CLARKE, G.J. Commission on hereditary disorders (letter). Am.J. Hum. Genet. 26:523-24, 1974.
15. HOLTZMAN, N.A. Public participation in genetic policymaking: The Mary-land Commission on Hereditary Disorders. In Genetics and the Law II, edited by A. MILUNKSY and G.J. ANNAS. New York: Plenum, 1980. 247-55.
16. HOLTZMAN, C.; SLAZYK, W.E.; CORDERO, J.F.; et al. Descriptive epidemiology of missed cases of phenylketonuria and congenital hypothyroidism. Pediatrics 78:553-58, 1986.
17. OFFICE OF TECHNOLOGY ASSESSMENT. U.S. Congress. Healthy Children: Investing in the Future. OTA-H-345. Washington, DC: GPO, 1988. 99-100.
18. FADEN, R.A.; HOLTZMAN, N.A.; and CHWALOW, A.J. Parental rights, child welfare, and public health: The case of PKU screening. Am.J. Public Health 72:1396-1400, 1982.
19. HOLTZMAN, N.A., and WATSON, M.S., eds. Promoting Safe and Effective Genetic Testing in the United States: Final Report of the Task Force on Genetic Testing Baltimore: Johns Hopk'ins UP, 1998. 12-13.
20. BEAUCHAMP, T.L., and CIIILDRESS, J.F. Principles of Biomedical Ethics, 4th ed. Oxford: Oxford UP, 1994. 179, 128, 142.
21. BLOCHE, M.G. Clinical counseling and the problem of autonomy-negating influence. In HI\f, AIDS and Childbearing: Public Policy, Private Lives, edited by R.R. FADEN and N.E. KASS. New York: Oxford UP, 1996. 257-319.
22. LANTOS, J.L). Shpuld we always tell children the truth? Persp. Biol. Med. 40: 78-92, 199Q.
23. HOLTZMAN, N.A.; FADEN, F;; CHWALOW, A.J.; and HORN, S. Effect of informed parental consent on mothers' knowledge of newborn screening. Pediatrics' 73:807-12, 1983.
24. POLLITT, R.J.; GREEN, A.; McCABE, C.J.; et al. Neonatal screening for inborn errors of metabolism: Cost, yield, and outcome. Health Technol. Assessment 1: 1997.
25. CLAYTON, E.W. Screening and treatment of newborns. Houston Law Review 29:85-148, 1992.
26. HOLTZMAN, N.A. A new basis for genetic screening policy. In New Horizons in Neonatal Screening, edited byJ.-P. FARRIAX andJ.-L. DHONDT. New York: Elsevier, 1994. 3-13.
27. COMMITTEE ON GENETICS. American Academy of Pediatrics. Newborn Screening Fact Sheets. Pediatrics. 98:473-501, 1996.
28. KNOPPERS, B.M. Newborn screening and informed consent. In NewHorizons in Neonatal Screening, edited byJ.-P. FARRIAUX andJ.-L. DOHONDT. Amsterdam: Elsevier Science, 1994. 15, 18, 19.
29. KOPPELMAN, L. Genetic screening in newborns: Voluntary or compulsory? Persp. Biol. Med. 21:83-89, 1978.
30. CASKEY, C.T. DNA-based medicine: Prevention and therapy. In-The Code of Codes: Scienlic and Social Issues in the Human Genome Project, edited by DJ. KEVLES and L. HOOD. Cambridge: Harvard UP, 1992. 112-135.
31. SWEETMAN, L. Newborn screening by tandem mass spectrometry (MS-MS). Clinical Chemistry 42:345-46, 1996.
32. WILSON, J.M.G., and JUNGNER, G. Principles and Practice of Screening for Disease. Geneva: World Health Organization, 1968. 26-39.
33. WILSON, J.M.G. Current trends and problems in health screening.J. Clin. Path 26:555-63, 1973.
34. WORLD HEALTH ORGANIZATION. Screening for Inborn Errors of Metabolism. Geneva: WHO Technical Report Series, 1968.
35. HAGGARD, M.P. Hearing screening in children. Arch. Dis. Child. 65:119395, 1990.
36. HOLTZMAN, N.A. Putting screening into perspective: Criteria and expansion. Unpublished talk. Neonatal Screening Symposium, San Diego, March 1997.
37. U.S. PREVENTIVE SERVICES TASK FORCE. Guide to Clinical Preventive Services, 2nd ed. Baltimore: Williams and Wilkins, 1996. 496.
38. NITOWSKY, H.M. Prescriptive screening for inborn errors of metabolism: A critique. Am.J. Ment. Défie. 77:539-549, 1973.
39. ROTHENBERG, M.B., and SILLS, E.M. latrogencsis: The PKU anxiety syndrome./ Am. Acad. Child Psychiatry 7:689-692, 1968.
40. SORENSON, J.R.; LEVY, H.L.; MANGIONE, T.W.; et al. Parental response to repeat testing of infants with false-positive results in a newborn screening program. Pediatrics 73:183-87, 1984.
41. BODEGARD, G.; FRYO, K.; and LARSSON, A. Psychological reactions in 102 families with a newborn who has a falsely positive screening test for congenital hypothyroidism. Acta. Paediat. Scand. Supp. 304:3-21, 1983.
42. FRYO, K., and BODEGARD, G. Four-year follow-up of psychological reactions to false positive screening tests for congenital hypothyroidism. Acta. Paediat. Scand. 76:107-14, 1987.
43. TYMSTRA, T. False positive results in screening tests: experiences of parents of children screened for congenital hypothyroidism. Family Practice 3:92-96, 1986.
44. Li, K.; Tsui, M.; LEE,J.; and LAM, S. Two year follow-up study of paretal reaction to false positive screening test for congenital hypothyroidism. In Neonatal and Perinatal Screening: The Asian Pacic Perspectives, edited by S. LAM and C. PANG. Hong Kong: Chinese University of Hong Kong, 1995. 155-59.
45. HOLTZMAN, N.A. Genetic screening and public health. Am.J. Public Health 87:1275-76, 1997.
46. SEGAL, S. The enigma of galactosemia. International Pediatrics 7:75-82, 1992.
47. MURRAY, T.H. The Worth of a Child. Berkeley: U of California P, 1996. 97.
48. FOST, N. Genetic diagnosis and treatment. Am.J. Dis. Child. 147:1190-95, 1993.
49. MACREADY, R.A. PKU testing: A reply to Professor Cooper. Medical Tribune, 6 April 1966.